Wells Fargo’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-34,401
| Closed | -$2.75M | – | 7870 |
|
|
2021
Q1 | $2.75M | Sell |
34,401
-78,518
| -70% | -$6.13M | ﹤0.01% | 3408 |
|
|
2020
Q4 | $8.9M | Buy |
112,919
+2,777
| +3% | +$163K | ﹤0.01% | 2185 |
|
|
2020
Q3 | $4.84M | Buy |
110,142
+18,949
| +21% | +$934K | ﹤0.01% | 2539 |
|
|
2020
Q2 | $4.03M | Sell |
91,193
-12,807
| -12% | -$478K | ﹤0.01% | 2675 |
|
|
2020
Q1 | $3.73M | Sell |
104,000
-7,693
| -7% | -$437K | ﹤0.01% | 2477 |
|
|
2019
Q4 | $7.92M | Buy |
111,693
+39,976
| +56% | +$2.9M | ﹤0.01% | 2165 |
|
|
2019
Q3 | $5.37M | Sell |
71,717
-1,607
| -2% | -$136K | ﹤0.01% | 2478 |
|
|
2019
Q2 | $5.91M | Sell |
73,324
-8,066
| -10% | -$567K | ﹤0.01% | 2424 |
|
|
2019
Q1 | $5.44M | Sell |
81,390
-31,010
| -28% | -$2.35M | ﹤0.01% | 2471 |
|
|
2018
Q4 | $8.37M | Sell |
112,400
-41,320
| -27% | -$3.41M | ﹤0.01% | 1987 |
|
|
2018
Q3 | $14.2M | Sell |
153,720
-109,551
| -42% | -$10.4M | ﹤0.01% | 1792 |
|
|
2018
Q2 | $25.9M | Sell |
263,271
-15,763
| -6% | -$1.76M | 0.01% | 1312 |
|
|
2018
Q1 | $31.1M | Sell |
279,034
-335,650
| -55% | -$37.6M | 0.01% | 1168 |
|
|
2017
Q4 | $63.2M | Sell |
614,684
-230,378
| -27% | -$22.9M | 0.02% | 776 |
|
|
2017
Q3 | $79.6M | Sell |
845,062
-126,763
| -13% | -$10M | 0.02% | 647 |
|
|
2017
Q2 | $75.7M | Buy |
971,825
+103,155
| +12% | +$7.75M | 0.02% | 668 |
|
|
2017
Q1 | $69.6M | Sell |
868,670
-18,477
| -2% | -$1.47M | 0.02% | 684 |
|
|
2016
Q4 | $69.9M | Buy |
887,147
+83,703
| +10% | +$6.5M | 0.02% | 668 |
|
|
2016
Q3 | $62.7M | Buy |
803,444
+668,993
| +498% | +$48.5M | 0.02% | 680 |
|
|
2016
Q2 | $9.24M | Sell |
134,451
-93,208
| -41% | -$6.43M | ﹤0.01% | 1898 |
|
|
2016
Q1 | $16.2M | Buy |
227,659
+17,587
| +8% | +$1.1M | 0.01% | 1417 |
|
|
2015
Q4 | $13.1M | Sell |
210,072
-33,080
| -14% | -$2.02M | 0.01% | 1609 |
|
|
2015
Q3 | $13.8M | Sell |
243,152
-11,036
| -4% | -$584K | 0.01% | 1556 |
|
|
2015
Q2 | $13.6M | Sell |
254,188
-31,041
| -11% | -$1.51M | 0.01% | 1661 |
|
|
2015
Q1 | $13.5M | Buy |
285,229
+17,038
| +6% | +$754K | 0.01% | 1617 |
|
|
2014
Q4 | $11.6M | Sell |
268,191
-15,498
| -5% | -$633K | ﹤0.01% | 1693 |
|
|
2014
Q3 | $9.75M | Buy |
283,689
+2,517
| +0.9% | +$88.9K | ﹤0.01% | 1803 |
|
|
2014
Q2 | $10.3M | Buy |
281,172
+72,727
| +35% | +$2.47M | ﹤0.01% | 1798 |
|
|
2014
Q1 | $7.03M | Buy |
208,445
+8,757
| +4% | +$289K | ﹤0.01% | 2082 |
|
|
2013
Q4 | $6.77M | Buy |
199,688
+3,741
| +2% | +$130K | ﹤0.01% | 2030 |
|
|
2013
Q3 | $6.24M | Buy |
195,947
+1,950
| +1% | +$51.9K | ﹤0.01% | 2033 |
|
|
2013
Q2 | $4.38M | Buy |
+193,997
| New | +$4.2M | ﹤0.01% | 2222 |
|
Wells Fargo's CMD Position: Q2 2021 in Review
Wells Fargo sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 34,401 shares — an estimated $2.75M sold.
Wells Fargo first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $79.6M in Q3 2017. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Wells Fargo reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Wells Fargo sold 34,401 Cantel Medical Corporation shares in Q2 2021, an estimated $2.75M.
- Wells Fargo first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Wells Fargo's Cantel Medical Corporation position peaked at $79.6M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Wells Fargo's 13F filing for Q2 2021, filed 16 Aug 2021.